Future research should focus on variants related to JAM2, CMPK2, and NAA60, using more clinical data for validation, especially as the pathogenic effect of CMPK2 on PFBC has yet to be independently replicated by other research groups. The gene discussed is JAM2; the disease is bilateral striopallidodentate calcinosis.